AnalystsYale JenYale Jen's Stock Forecasts
AnalystsYale Jen
Sectors:
Analyst Ranking
Bottom 12%
#4076 out of 4572 analysts
Average Return
-25.14%
Win Rate
22%2 out of 9
Risk vs Reward
Poor
Good
Yale Jen's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Nls Pharmaceutics LtdNLSP | +80.00% | $0.60 | $1.08 | 2022-09-05 - 2023-09-05 | Strong Buy |
Evofem Biosciences IncEVFM | +38.95% | $0.34 | $0.48 | 2022-06-01 - 2022-08-10 | Strong Buy |
Yale Jen Analyst Color
Get additional color on Yale Jen's coverage of popular stocks
Yale Jen's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
In8bio IncINAB | 1 | Strong Buy | $7.50 | +635.29% | Initiates Coverage On | 2 months ago |
Silo Pharma IncSILO | 1 | Strong Buy | $10.00 | +440.54% | Initiates Coverage On | 8 months ago |
Bellerophon Therapeutics IncBLPH | 1 | Strong Buy | $35.00 | +34,213.73% | Initiates Coverage On | a year ago |
Nls Pharmaceutics LtdNLSP | 1 | Strong Buy | $6.00 | N/A | Initiates Coverage On | 2 years ago |
Evofem Biosciences IncEVFM | 1 | Strong Buy | $3.50 | N/A | Initiates Coverage On | 2 years ago |
Cingulate IncCING | 1 | Strong Buy | $170.00 | N/A | Initiates Coverage On | 2 years ago |
Vincerx Pharma IncVINC | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 3 years ago |
F Star Therapeutics IncFSTX | 1 | Strong Buy | $32.00 | N/A | Initiates Coverage On | 3 years ago |
Athenex IncATNXQ | 1 | Strong Buy | $720.00 | N/A | Initiates Coverage On | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.